Back to Stocks
Stock detail
Amgen Inc.
AMGNSTOCKS | US | NASDAQ | Healthcare | Drug Manufacturers - General
Profile snapshotUSD 393.1Market cap USD 212.2B
No local candle data found.
Recent detected patterns / setups
Latest 10 Market Radar results for this symbol.
PatternTFDetectedQuality
BullishOrder Block Setup15M28 Jul 26, 15:4578
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishMA 8/21 Crossover15M28 Jul 26, 15:4591
BullishOrder Block Setup15M28 Jul 26, 15:4578
BullishOliver Kell Momentum Setup15M28 Jul 26, 15:4583
BullishMA 8/21 Crossover15M28 Jul 26, 15:4591
BullishMA 8/21 Crossover4H28 Jul 26, 13:3067
BullishFVG Reaction Setup4H + 15M28 Jul 26, 15:4568
BullishOliver Kell Momentum Setup4H28 Jul 26, 13:3079
BullishOrder Block Setup4H28 Jul 26, 13:3082
Annual
Annual fundamentals
2025 vs previous annual period
Metric202020212022202320242025
Total revenueUSD 25.4B+8.8%USD 26B+2.2%USD 26.3B+1.3%USD 28.2B+7.1%USD 33.4B+18.6%USD 36.7B+9.9%
Net incomeUSD 7.3B-7.4%USD 5.9B-18.9%USD 6.6B+11.2%USD 6.7B+2.5%USD 4.1B-39.1%USD 7.7B+88.5%
Net profit margin28.6%-14.9%22.7%-20.6%24.9%+9.7%23.8%-4.3%12.2%-48.6%21.0%+71.5%
EPS12.4-4.3%10.34-16.6%12.18+17.8%12.56+3.1%7.62-39.3%14.33+88.1%
Quarterly
Quarterly fundamentals
Q1 2026 vs same quarter previous year
MetricQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Total revenueUSD 9.1B+10.9%USD 8.1B+9.4%USD 9.2B+9.3%USD 9.6B+12.4%USD 9.9B+8.9%USD 8.6B+5.8%
Net incomeUSD 627M-18.3%USD 1.7B+1631.0%USD 1.4B+92.0%USD 3.2B+13.6%USD 1.3B+112.6%USD 1.8B+5.1%
Net profit margin6.9%-26.3%21.2%+1499.1%15.6%+75.6%33.7%+1.1%13.5%+95.2%21.1%-0.6%
EPS1.17-18.2%3.22+1633.3%2.66+91.4%5.98+13.5%2.47+111.1%3.37+4.7%
Ownership
Institutional ownership summary
2026 Q2, quarter ended 2026-06-30
PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call
2026 Q22026-06-30